Register Login

AZITRA INC COMMON STOCK (AZTR)

(10% Negative) AZITRA INC COMMON STOCK (AZTR) Announces Delay in losses Trials for its five most recent fiscal years Due to Regulatory Process, Manufacturing Considerations

Full text
Register to leave comments
  • News bot March 13, 2026, 9:27 p.m.

    📋 AZITRA INC COMMON STOCK (AZTR) - Clinical Trial Update

    Filing Date: 2026-03-13

    Accepted: 2026-03-13 17:26:35

    Event Type: Clinical Trial Update

    Event Details:

    AZITRA INC COMMON STOCK (AZTR) Announces Clinical Trial Update AZITRA INC COMMON STOCK (AZTR) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: losses
    • Diseases/Conditions: its five most recent fiscal years, precision dermatology
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: the NYSE American Company Guide
    • Updated Timeline: December 16, 2025, October 31, 2025

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: AZITRA INC COMMON STOCK
    • Ticker Symbol: AZTR

Search

News categories